Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKromek Regulatory News (KMK)

Share Price Information for Kromek (KMK)

Share Price is delayed by 15 minutes
Get Live Data
7.85    -0.25 (-3.03%)
Bid:
7.70
Ask:
8.00
Spread: 0.30 (3.896%)
Market Cap: £52.42m
KMK Live PriceLast checked at - London Stock Exchange

Intraday Kromek Share Chart

Directorate Changes

16 Dec 2020 07:00

RNS Number : 7767I
Kromek Group PLC
16 December 2020
 

16 December 2020

 

Kromek Group plc

("Kromek" or the "Group")

 

Directorate Changes

 

Kromek (AIM: KMK), a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce the appointment of Mr Berry Beumer, Chief Operating Officer ("COO"), as an Executive Director of the Group with immediate effect. Furthermore, Mr Rakesh Sharma OBE, who joined the Group as a Non-executive Director in October 2020, will replace Sir Peter Williams CBE as Non-executive Chairman, who is retiring from the Board on 1 January 2021.

 

Mr Albertus ("Berry") Beumer, aged 56, is a technology business executive with extensive experience of delivering revenue growth in the analytical instrument, high-frequency communications equipment and optoelectronic and semiconductor materials industries. Since joining Kromek as COO in 2015, based in the Group's Pennsylvania facility, he has played an instrumental role in the growth of the business through the expansion of Kromek's US customer base and operations in both medical imaging and nuclear detection. Prior to Kromek, he held a number of senior roles at businesses in Europe and the US, including 14 years as Vice President, Sales and Marketing at XOS, Inc., part off Danaher Inc., a leading manufacturer of application-specific x-ray analysers, where he was responsible for driving the strategic direction of their x-ray elemental technology business.

 

Rakesh Sharma OBE, Chairman Designate of Kromek, said: "It is a great honour to succeed Sir Peter as Chairman. I thank him for his valuable contribution which has enabled Kromek to truly transform during his tenure, and we wish him all the best in his retirement. I am also pleased to welcome Berry to the Board. He has played a fundamental role in our growth as part of the executive team and we look froward to further benefitting from his expertise in his new role. Kromek is an ambitious company with advanced technology, extensive IP and a foothold in some of the most important markets today. We are excited about the future and delivering on our plans to secure sustainable growth and shareholder value."

 

Sir Peter Williams added: "It has been a pleasure to be a part of Kromek's journey as it has matured and scaled up over recent years into a truly international business with diversified revenue streams. As I retire, I leave the role of Chairman in the very capable hands of Rakesh who brings tremendous experience in overseeing the growth of international hi-tech engineering and manufacturing businesses. I also congratulate Berry Beumer on joining the Board and, following Paul Farquhar's recent appointment, I leave Kromek with a refreshed and powerful team at the helm under Arnab Basu's leadership. I will be following the business closely and look forward to watching its continued progress."

 

Mr Beumer holds 80,000 ordinary shares in the Group, representing 0.02% of the issued share capital. There are no other matters required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies as regards Mr Beumer's appointment.

 

 

For further information, please contact:

 

Kromek Group plc

 

Arnab Basu, CEO

Paul Farquhar, CFO

 

+44 (0)1740 626 060

Cenkos Securities plc (Nominated Adviser and Broker)

 

Max Hartley (NOMAD)

Julian Morse (Sales)

 

+44 (0)20 7397 8900

Luther Pendragon (PR)

 

Harry Chathli

Claire Norbury

Alexis Gore

Joe Quinlan

+44 (0)20 7618 9100

 

 

About Kromek Group plc

 

Kromek Group plc is a technology group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

 

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

 

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

 

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

 

Currently, the Group has over one hundred full-time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and

https://twitter.com/kromekgroup.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABELLFBLLEFBF
Date   Source Headline
2nd Sep 20158:56 amRNSHolding(s) in Company
28th Aug 20151:18 pmRNSHolding(s) in Company
28th Aug 201512:13 pmRNSTotal Voting Rights
28th Aug 20159:08 amRNSHolding(s) in Company
26th Aug 20153:59 pmRNSHolding(s) in Company
20th Aug 20158:23 amRNSHolding(s) in Company
17th Aug 201512:11 pmRNSResults of Firm Placing and Open Offer
30th Jul 201512:16 pmRNSDirector Share Purchase
30th Jul 201511:39 amRNSFirm Placing and Open Offer Timetable
30th Jul 20157:01 amRNSFirm Placing and Open Offer to raise up to £11.0m
30th Jul 20157:01 amRNSFinal Results
1st Jul 20155:13 pmRNSHolding(s) in Company
1st Jul 20155:07 pmRNSHolding(s) in Company
18th May 20157:00 amRNSMultiple contract wins with global OEMs
28th Apr 20157:00 amRNSChange of Adviser
17th Apr 20157:00 amRNSBusiness and Trading Update
17th Apr 20157:00 amRNSKromek awarded further contract by DARPA
27th Mar 20157:00 amRNSDirectorate Change
16th Mar 20157:00 amRNSCredit facility with HSBC
10th Feb 20158:56 amRNSBlock Listing Update
9th Feb 20157:00 amRNSGlobal contract wins across all segments
14th Jan 20157:00 amRNSInterim Results
14th Jan 20157:00 amRNSExtension to nuclear detection contract with DARPA
11th Dec 20147:00 amRNSKromek Contract Wins
9th Oct 20149:15 amRNSDirector's Dealing
1st Oct 201411:56 amRNSResult of AGM
22nd Sep 20147:00 amRNSProgress with global OEM contract
10th Sep 20145:46 pmRNSAnnual Report and Accounts and Notice of AGM
28th Aug 20147:00 amRNSFinal Results
4th Aug 20147:00 amRNSContract Win
31st Jul 20147:00 amRNSBlock Listing Update and Additional Listing
22nd Jul 20147:00 amRNSContract Win and Update on Trading
23rd Jun 20147:00 amRNSContract Wins
5th Jun 20147:00 amRNSNew Loan Facility
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
7th Apr 20145:03 pmRNSDirector/PDMR Shareholding
4th Apr 20147:00 amRNSNew Contract Signed in Medical Imaging Market
28th Mar 20147:01 amRNSTrading Statement
27th Feb 20147:00 amRNSNew Orders Received in Medical Imaging
18th Feb 20147:00 amRNSDirectorate Change
30th Jan 20143:56 pmRNSAdditional Listing
8th Jan 20147:00 amRNSHalf Yearly Report
10th Dec 20137:00 amRNSDirectorate Change
27th Nov 20137:00 amRNSBottle Scanner Orders and New Accreditation
5th Nov 20137:00 amRNSOrders and payments received from global OEMs
31st Oct 20131:28 pmRNSTotal Voting Rights
24th Oct 201311:44 amRNSHolding(s) in Company
21st Oct 20136:08 pmRNSHolding(s) in Company
16th Oct 20137:00 amRNSAdmission and First Day of Dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.